Evaluation of Efficacy and Safety of MEDI2070 in Patients With Active, Moderate-to-severe Crohn's Disease.
Public ClinicalTrials.gov record NCT01714726. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2a Study to Evaluate the Efficacy and Safety of MEDI2070 in Subjects With Moderate to Severe Crohn's Disease Who Have Failed or Are Intolerant to Anti-tumor Necrosis Factor-alpha Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study is designed to evaluate the clinical efficacy and safety of MEDI2070 as compared to placebo. Investigational product will be administered as intravenous infusion in double-blind period, and as a subcutaneous injection in open-label period
Study identification
- NCT ID
- NCT01714726
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 121 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2013
- Primary completion
- May 19, 2014
- Completion
- Dec 13, 2016
- Last update posted
- May 25, 2021
2013 – 2016
United States locations
- U.S. sites
- 26
- U.S. states
- 15
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Encinitas | California | 92024 | — |
| Research Site | Los Angeles | California | 45242 | — |
| Research Site | San Diego | California | 92114 | — |
| Research Site | Torrance | California | 90505 | — |
| Research Site | Lakewood | Colorado | 80215 | — |
| Research Site | Jacksonville | Florida | 32256 | — |
| Research Site | Miami | Florida | 33136 | — |
| Research Site | Winter Park | Florida | 32789 | — |
| Research Site | Macon | Georgia | 31201 | — |
| Research Site | Chicago | Illinois | 60637 | — |
| Research Site | Baton Rouge | Louisiana | 70809 | — |
| Research Site | Hammond | Louisiana | 70403 | — |
| Research Site | Baltimore | Maryland | 21201 | — |
| Research Site | Chevy Chase | Maryland | 20815 | — |
| Research Site | Ann Arbor | Michigan | 48109 | — |
| Research Site | Troy | Michigan | 48098 | — |
| Research Site | Belton | Missouri | 64012 | — |
| Research Site | New York | New York | 10021 | — |
| Research Site | New York | New York | 10029 | — |
| Research Site | Asheville | North Carolina | 28801 | — |
| Research Site | Charlotte | North Carolina | 28207 | — |
| Research Site | Cincinnati | Ohio | 45219 | — |
| Research Site | Lima | Ohio | 45806 | — |
| Research Site | Germantown | Tennessee | 38138 | — |
| Research Site | San Antonio | Texas | 78229 | — |
| Research Site | Seattle | Washington | 98195 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 54 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01714726, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 25, 2021 · Synced Sep 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01714726 live on ClinicalTrials.gov.